UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Parasiticide showed antiviral effect as potential Covid-19 drug’
by Jeong Sae-im
2020-04-24 12:27
French envoy visits Pasteur Korea to watch Covid-19 research
by Jeong Sae-im
2020-04-23 17:13
4 drugs recorded two-digit sales growth in Q1 despite Covid-19
by Jeong Sae-im
2020-04-23 12:18
Medytox’s faking data unpunishable due to expired statute of limitations
by Jeong Sae-im
2020-04-22 11:28
Whistleblowers, shareholders furious over Medytox’s rebuttal
by Jeong Sae-im
2020-04-21 15:19
라인
ImmuneMed confident of drug candidate’s effect on Covid-19
by Jeong Sae-im
2020-04-21 13:23
‘Stem cell therapy more effective on Covid-19’
by Jeong Sae-im
2020-04-21 11:01
Osang Healthcare wins US nod for Covid-19 test kit
by Jeong Sae-im
2020-04-20 11:58
‘Natural Killer cells predict immunotherapy’s efficacy in lung cancer patients’
by Jeong Sae-im
2020-04-17 16:07
Medytox CEO charged with making, selling botulinum toxin illegally
by Jeong Sae-im
2020-04-17 16:00
라인
Bukwang to test its antiviral drug against Covid-19
by Jeong Sae-im
2020-04-16 12:20
What are the odds for successful Invossa trials in US?
by Jeong Sae-im
2020-04-14 15:01
FDA OKs resumption of phase-3 Invossa trial in US
by Jeong Sae-im
2020-04-13 11:58
Korean diagnostics industry to enjoy unprecedented boom
by Jeong Sae-im
2020-04-09 14:30
Executive salaries highest at Samsung Biologics, Celltrion
by Jeong Sae-im
2020-04-09 11:13
라인
No Korean firms have entered trials to test COVID-19 drug candidates
by Jeong Sae-im
2020-04-08 16:15
3 drug candidates authorized to treat COVID-19 patients
by Jeong Sae-im
2020-04-07 15:50
COVID-19 plasma therapy hits snag due to blood supply regulation
by Jeong Sae-im
2020-04-06 15:22
ImmuneMed under fire for inflating drug’s effect against COVID-19
by Jeong Sae-im
2020-03-27 11:49
Has Moon promised beyond Korean equipment makers’ capacity?
by Jeong Sae-im
2020-03-26 14:56
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top